CD4 and COVID-19: Our two-year follow-up shows that PWH with a CD4+ T-cell count < 200 cells per μL had consistently lower antibody levels after a primary COVID-19 vaccination series compared to PWH with a CD4+ T-cell count ≥ 200 cells per μL.